Cargando…
Abnormal PTBP1 Expression Sustains the Disease Progression of Multiple Myeloma
Multiple myeloma (MM) is a hematopoietic malignancy characterized by heterogeneity, which corresponds to alternative splicing (AS) profiles and disadjust gene expression. Bioinformatics analysis of AS factors possibly related to MM progression identified the polypyrimidine tract binding protein (PTB...
Autores principales: | Bai, Hua, Chen, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321530/ https://www.ncbi.nlm.nih.gov/pubmed/32655719 http://dx.doi.org/10.1155/2020/4013658 |
Ejemplares similares
-
Multiple determinants of splicing repression activity in the polypyrimidine tract binding proteins, PTBP1 and PTBP2
por: Keppetipola, Niroshika M., et al.
Publicado: (2016) -
PTBP1 and PTBP2 impaired autoregulation of SRSF3 in cancer cells
por: Guo, Jihua, et al.
Publicado: (2015) -
Abnormal repression of SHP-1, SHP-2 and SOCS-1 transcription sustains the activation of the JAK/STAT3 pathway and the progression of the disease in multiple myeloma
por: Beldi-Ferchiou, Asma, et al.
Publicado: (2017) -
Polypyrimidine tract binding proteins PTBP1 and PTBP2 interact with distinct proteins under splicing conditions
por: Pina, Jeffrey M., et al.
Publicado: (2022) -
Psd-95 is post-transcriptionally repressed during early neural development by PTBP1 and PTBP2
por: Zheng, Sika, et al.
Publicado: (2012)